Caption Management’s Moderna MRNA Stock Holding History

Caption Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55.6M	Buy	1,094,300 +450,000	+70%	+$21M	0.32%	63
2025 Q4	$19M	Buy	644,300 +477,300	+286%	+$13M	0.13%	184
2025 Q3	$4.31M	Buy	+167,000	New	+$4.66M	0.03%	546
2025 Q1	–	Sell	-9,000	Closed	-$374K	–	1850
2024 Q4	$374K	Sell	9,000 -39,000	-81%	-$1.86M	﹤0.01%	1174
2024 Q3	$3.21M	Buy	48,000 +18,000	+60%	+$1.65M	0.05%	422
2024 Q2	$3.56M	Buy	+30,000	New	+$3.8M	0.05%	360
2021 Q4	–	Sell	-74,600	Closed	-$28.7M	–	1820
2021 Q3	$28.7M	Sell	74,600 -107,900	-59%	-$39.8M	0.33%	54
2021 Q2	$42.9M	Buy	182,500 +162,500	+813%	+$29M	0.56%	25
2021 Q1	$2.62M	Sell	20,000 -138,000	-87%	-$20M	0.06%	437
2020 Q4	$16.5M	Sell	158,000 -114,000	-42%	-$11.5M	0.38%	59
2020 Q3	$19.2M	Buy	+272,000	New	+$19M	0.45%	34

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caption Management's MRNA Position: Q4 2025 in Review

Caption Management sold out of Moderna (MRNA) in Q4 2025, closing a stake of 66,747 shares — an estimated $1.81M sold.

Caption Management first reported a position in MRNA in Q4 2020 and held it in 3 quarters. The position peaked at $3.06M in Q4 2020. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

Caption Management reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
Caption Management sold 66,747 Moderna shares in Q4 2025, an estimated $1.81M.
Caption Management first reported a position in Moderna in Q4 2020 and held it in 3 quarters.
Caption Management's Moderna position peaked at $3.06M in Q4 2020.
672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.